HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gursharan S Chhatwal Selected Research

Rheumatic Fever (Acute Articular Rheumatism)

1/2012Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.
12/2009Identification of active variants of PARF in human pathogenic group C and group G streptococci leads to an amended description of its consensus motif.
9/2009Autoantigens identified by screening a human heart cDNA library with acute rheumatic fever sera.
1/2009Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever.
9/2008Evaluation of the potential of animal streptococcal isolates belonging to serogroups C and G to elicit acute rheumatic fever.
6/2007Identification of a streptococcal octapeptide motif involved in acute rheumatic fever.
6/2003Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen.
1/2002The potential for vaccine development against rheumatic fever.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gursharan S Chhatwal Research Topics

Disease

22Infections
01/2014 - 12/2002
8Rheumatic Fever (Acute Articular Rheumatism)
01/2012 - 01/2002
5Streptococcal Infections (Streptococcal Infection)
12/2009 - 06/2003
1Mastitis
07/2011
1Autoimmune Diseases (Autoimmune Disease)
09/2009
1Foreign Bodies (Foreign Body)
10/2003
1Pneumococcal Infections
07/2003
1Rheumatic Diseases (Rheumatism)
06/2003

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2012 - 06/2003
6CollagenIBA
01/2012 - 06/2003
4Peptides (Polypeptides)IBA
01/2012 - 06/2007
4Virulence Factors (Pathogenicity Factors)IBA
07/2011 - 10/2003
4AntibodiesIBA
07/2007 - 06/2003
3Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 02/2005
3PlasminogenIBA
11/2010 - 07/2003
3VaccinesIBA
07/2007 - 01/2002
2Immunoglobulin G (IgG)IBA
09/2009 - 06/2007
2Collagen Type IV (Type IV Collagen)IBA
09/2008 - 06/2003
1Trimethoprim (Proloprim)FDA LinkGeneric
01/2014
1Streptococcus pneumoniae plY proteinIBA
02/2012
1Plasminogen Activators (Plasminogen Activator)IBA
11/2010
116S Ribosomal RNAIBA
04/2010
1Extracellular Matrix ProteinsIBA
12/2009
1AutoantigensIBA
09/2009
1Interleukin-12 (IL 12)IBA
12/2007
1Deoxyribonucleases (DNase)FDA Link
08/2007
1Carrier Proteins (Binding Protein)IBA
06/2007
1Recombinant ProteinsIBA
06/2007
1asialo GM1 gangliosideIBA
04/2005
1Interleukin-6 (Interleukin 6)IBA
04/2005
1Interferon-gamma (Interferon, gamma)IBA
04/2005
1InterleukinsIBA
04/2005
1CytokinesIBA
04/2005
1Complementary DNA (cDNA)IBA
05/2004
1StreptokinaseFDA Link
01/2004
1Fibrinogen (Factor I)FDA Link
01/2004
1EnzymesIBA
12/2003
1Fibronectins (Fibronectin)IBA
12/2003
1PolymersIBA
10/2003
1Hyaluronic Acid (Hyaluronan)IBA
06/2003
1Capsules (Microcapsules)IBA
06/2003
1AutoantibodiesIBA
06/2003
1Gentamicins (Gentamicin)FDA LinkGeneric
02/2003
1NF-kappa B (NF-kB)IBA
12/2002
1Cytochalasin DIBA
12/2002

Therapy/Procedure

1Therapeutics
12/2006